Following that, data from the TRIUMPH-1 trial evaluated adults without diabetes over an 80-week timeline
This decision prioritizes affordability and access for patients, while the main patent dispute continues in the Delhi High Court
Johnson DE, Wobken JD, Landrum BG
Rising Cases of Diabetes and Obesity are Driving the UK As of 2024, there are 4.6 million diagnosed diabetic cases in the UK, plus an estimated 1.3 million undiagnosed
Abrupt discontinuation may reverse appetite control benefits
The pharmaceutical composition comprises semaglutide and pharmaceutically acceptable excipients selected from the group consisting of permeation enhancer, binders, solubilzer, diluents, disintegrants, lubricants, glidants, antioxidants, pH adjusting agents, flavouring agent, colorants and sweetening agent etc